Instead of ablating the whole prostate gland, with its risk for collateral damage, a focal approach ablates just the index lesion and reduces the risk for harm.

Investigators reviewed biopsy specimens from 758 prostate cancer (PCa) patients who underwent RP 2012 to 2016, identifying index and non-index lesions for each patient.

Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S. To develop a consistent method of estimating prostate cancer ...

When a new, more sensitive imaging tool hit the scene, it became the go-to tool for detecting recurrent prostate cancer. But now experts are rethinking how, or whether, to act on positive findings.

Prostate cancer focal therapy oncologic and functional outcomes appear similar for MRI-visible and MRI-invisible lesions.

A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, "Deep learning-assisted lesion segmentation in PET/CT imaging: A feasibility study for salvage radiation ...

Using AI to measure prostate cancer lesions could aid diagnosis and treatment Mass General Brigham researchers developed an AI model that can identify and measure aggressive prostate cancer lesions.

A new study finds that harms of overdiagnosing prostate cancer is lessened when MRI is used as well as PSA tests.

Using AI to measure prostate cancer lesions could aid diagnosis and treatment Date: October 29, 2024 Source: Mass General Brigham Summary: Prostate cancer is the second most common cancer in men ...